Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists
Author:
Affiliation:
1. RTI Health Solutions Barcelona Spain
2. Aarhus University Aarhus Denmark
3. Boehringer Ingelheim International GmbH Ingelheim am Rhein Germany
4. RTI Health Solutions Waltham Massachusetts USA
5. RTI Health Solutions Philadelphia Pennsylvania USA
Funder
Boehringer Ingelheim
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5432
Reference30 articles.
1. Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
2. Pharmacology and Therapeutics of Bronchodilators
3. A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
4. Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials
5. Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery and Identification of Novel 5-Hydroxy-4H-benzo[1,4]oxazin-3-one Derivatives as Potent β2-Adrenoceptor Agonists through Structure-Based Design, Synthesis, and Biological Evaluation;Journal of Medicinal Chemistry;2024-02-13
2. Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies;Neurotherapeutics;2023-03
3. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023
4. The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly;Contrast Media & Molecular Imaging;2022-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3